Pancreatic Cancer Research

ResearcherSoochow UniversityNo recent work listed

Yulan Zhu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1182-5396; OpenAlex author ID A5101766524. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 2 papers

Papers 3

  1. Prognostic values of B7-H3, B7-H4, and HHLA2 expression in human pancreatic cancer tissues based on mIHC and spatial distribution analysis. Co-author DOI 10.1016/j.prp.2022.153911↗
  2. Increased expression of METTL3 in pancreatic cancer tissues associates with poor survival of the patients. Co-author DOI 10.1186/s12957-022-02743-7↗
  3. miR-615-5p is epigenetically inactivated and functions as a tumor suppressor in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/onc.2014.101↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Lujun Chen · 2 shared papers, 2022 · strength 0.32
  2. Yuan Li · 1 shared paper, 2022 · strength 0.16
  3. Xuemin Chen · 1 shared paper, 2022 · strength 0.15
  4. Keiko Shinjo · 1 shared paper, 2015 · strength 0.04
  5. Wen Gao · 1 shared paper, 2015 · strength 0.04
  6. Yumei Gu · 1 shared paper, 2015 · strength 0.04
  7. Yi Miao · 1 shared paper, 2015 · strength 0.04
  8. Huihua Cai · 1 shared paper, 2015 · strength 0.04
  9. Min Tu · 1 shared paper, 2015 · strength 0.04
  10. Yutaka Kondo · 1 shared paper, 2015 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.